Linked Life Data

20716876

Source:http://linkedlifedata.com/resource/pubmed/id/20716876

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2010-8-18
pubmed:abstractText
Bone metastasis is a frequent complication of malignant cancer. Previous clinical trials of bone metastasis have largely focused on skeletal related events (SREs) as objective end-points. However, a subjective health-related outcome such as quality of life (QOL) is also a first-priority principle for all patients with malignant cancer. In response to the need for a comprehensive module to evaluate bone metastasis-specific QOL, the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group has developed a Quality of Life Questionnaire for patients with Bone Metastases (EORTC QLQ-BM22). In this study, we introduce the official Japanese version of the EORTC QLQ-BM22 as a module to evaluate QOL in patients with bone metastasis. This module has been developed to be used together with the EORTC QLQ-C30, a QOL scale for patients with cancer, or with its shortened version, EORTC QLQ-C-15-PAL.
pubmed:language
jpn
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0385-0684
pubmed:author
pubmed:issnType
Print
pubmed:volume
37
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1507-12
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
[The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire for Japanese patients with bone metastases--The Japanese version of the EORTC QLQ-BM22].
pubmed:affiliation
Dept. of Urology, Kitasato University School of Medicine.
pubmed:publicationType
Journal Article, English Abstract